80.5 EUR
0.5
0.63%
Last update Dec 15, 7:37 PM CET
Main market
Day range
80
81
Previous close
80
Open
81
Access this stock data via API
Subscribe
Protagonist Therapeutics Inc.
80.50
0.50
0.63%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 370.2M 60M 26.6M 27.4M
Cost of revenue
Gross profit
Operating expense
Research & development 117.7M 120.2M 126.2M 126.0M
Selling general and admin 37.0M 33.5M 31.7M 27.2M
Other operating expenses
Operating income 215.5M -93.7M -131.4M -125.8M
Non operating interest income
Income 22.4M 14.9M 4.1M 443K
Expense 0 0
Other income expense 213.1K -201K -80K -149K
Pretax income 238.1M -79.0M -127.4M -125.6M
Tax provision 3.6M 0 0
Net income 234.5M -79.0M -127.4M -125.6M
Basic EPS 4.5 -1.4 -2.6 -2.7
Diluted EPS 4.2 -1.4 -2.6 -2.7
Basic average shares 52.5M 59.6M 51.0M 48.2M
Diluted average shares 52.5M 59.6M 51.0M 48.2M
EBITDA 218.0M -90.3M -128.0M -123.1M
Net income from continuing op. 234.5M -79.0M -127.4M -125.6M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 44 minutes

14:15
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).